Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data.
about
Adverse effects of antimicrobials via predictable or idiosyncratic inhibition of host mitochondrial componentsAnimal models of osteoarthritis: classification, update, and measurement of outcomesRisks associated with the therapeutic use of fluoroquinolones.Low-level laser therapy and sodium diclofenac in acute inflammatory response induced by skeletal muscle trauma: effects in muscle morphology and mRNA gene expression of inflammatory markers.Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age.Ciprofloxacin safety in paediatrics: a systematic review.Fluoroquinolone resistance in campylobacter.Useful animal models for the research of osteoarthritis.Involvement of the endocannabinoid system in osteoarthritis pain.Safety issues and drug-drug interactions with commonly used quinolones.Levofloxacin increases the effect of serum deprivation on anoikis of rat nucleus pulposus cells via Bax/Bcl-2/caspase-3 pathway.Fluoroquinolone-Associated Tendinopathy: Does Levofloxacin Pose the Greatest Risk?Effect of berberine on Escherichia coli, Bacillus subtilis, and their mixtures as determined by isothermal microcalorimetry.Adjunctive use of combination of super-pulsed laser and light-emitting diodes phototherapy on nonspecific knee pain: double-blinded randomized placebo-controlled trial.Tuberculosis prophylaxis with levofloxacin in liver transplant patients is associated with a high incidence of tenosynovitis: safety analysis of a multicenter randomized trial.Prevention of chronic Pseudomonas aeruginosa infection in people with cystic fibrosis.
P2860
Q24616291-BCC06ABF-B217-429D-A3BB-8D855A6C7E01Q28072990-B2239320-297C-4AEF-8DE0-DDB9E8275C5FQ34343391-21D4337F-3FC9-4CE9-8A8D-800842C982C1Q34400062-6D3407AB-05F0-4E00-BF37-F0347C23A660Q34596303-62B6ED9D-5023-40FC-AF92-2E60A6DC5642Q35161454-1DDFF176-CB19-4F3F-B285-742A73ED3039Q37764099-22871410-4E17-44E4-85CC-E81057BE9119Q38090972-21F7F5FF-6E24-411C-9BBE-B20DCAFF3566Q38185076-ED793C12-DC7A-42E0-AA6E-362F38A24B16Q38271318-D9135199-DD53-46D3-88D9-EBB836C58D34Q38304165-D3A0483E-8717-4EC1-8264-D678FE16F0D9Q38823701-F0A68FD2-3324-4681-B21A-70D059433607Q39571791-96613499-8EBF-4B3D-9CF4-84C80CBC6572Q48075926-66A180DB-C64F-44BA-81E1-FCC51446DD91Q50450994-D873A6A8-0CD0-4AD0-B16A-CA6D06D5AA15Q52847673-7D0A6A19-57FB-4484-856B-1AAD41D2B94E
P2860
Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data.
@ast
Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data.
@en
type
label
Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data.
@ast
Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data.
@en
prefLabel
Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data.
@ast
Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data.
@en
P2093
P1476
Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data.
@en
P2093
Hartmut Lode
Judith Sendzik
Ralf Stahlmann
P304
P356
10.1016/J.IJANTIMICAG.2008.08.004
P577
2008-10-02T00:00:00Z